170 related articles for article (PubMed ID: 18409529)
1. [Relationship between hyperuricemia and metabolic syndrome].
Yamasaki T; Tomita K
Nihon Rinsho; 2008 Apr; 66(4):766-70. PubMed ID: 18409529
[TBL] [Abstract][Full Text] [Related]
2. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
Battelli MG; Bortolotti M; Polito L; Bolognesi A
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome, diabetes, and hyperuricemia.
Li C; Hsieh MC; Chang SJ
Curr Opin Rheumatol; 2013 Mar; 25(2):210-6. PubMed ID: 23370374
[TBL] [Abstract][Full Text] [Related]
4. [Hyperuricemia and uro-nephrological disorders].
Hurtes X; Meria P
Presse Med; 2011 Sep; 40(9 Pt 1):865-8. PubMed ID: 21684106
[TBL] [Abstract][Full Text] [Related]
5. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A
J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104
[TBL] [Abstract][Full Text] [Related]
6. Uric acid and cardiovascular risk.
Feig DI; Kang DH; Johnson RJ
N Engl J Med; 2008 Oct; 359(17):1811-21. PubMed ID: 18946066
[No Abstract] [Full Text] [Related]
7. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.
Nakagawa T; Tuttle KR; Short RA; Johnson RJ
Nat Clin Pract Nephrol; 2005 Dec; 1(2):80-6. PubMed ID: 16932373
[TBL] [Abstract][Full Text] [Related]
8. The role of hyperuricemia in vascular disorders.
Edwards NL
Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
[TBL] [Abstract][Full Text] [Related]
9. Chronic hyperuricemia, uric acid deposit and cardiovascular risk.
Grassi D; Ferri L; Desideri G; Di Giosia P; Cheli P; Del Pinto R; Properzi G; Ferri C
Curr Pharm Des; 2013; 19(13):2432-8. PubMed ID: 23173592
[TBL] [Abstract][Full Text] [Related]
10. Hyperuricemia, cardiovascular disease, and the metabolic syndrome.
Indraratna PL; Williams KM; Graham GG; Day RO
J Rheumatol; 2009 Dec; 36(12):2842-3; author reply 2844. PubMed ID: 19966196
[No Abstract] [Full Text] [Related]
11. Medical implications of hyperuricemia.
Sachs L; Batra KL; Zimmermann B
Med Health R I; 2009 Nov; 92(11):353-5. PubMed ID: 19999892
[No Abstract] [Full Text] [Related]
12. [Disorder of purine metabolism].
Fujimori S
Nihon Rinsho; 2004 Jun; 62(6):1119-24. PubMed ID: 15206151
[TBL] [Abstract][Full Text] [Related]
13. Uric Acid as a Cause of the Metabolic Syndrome.
King C; Lanaspa MA; Jensen T; Tolan DR; Sánchez-Lozada LG; Johnson RJ
Contrib Nephrol; 2018; 192():88-102. PubMed ID: 29393133
[TBL] [Abstract][Full Text] [Related]
14. [Lozartan potential in hyperuricemia correction].
Ter Arkh; 2011; 83(10):45-8. PubMed ID: 22185025
[TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress.
Battelli MG; Polito L; Bolognesi A
Atherosclerosis; 2014 Dec; 237(2):562-7. PubMed ID: 25463089
[TBL] [Abstract][Full Text] [Related]
16. [Uric acid as a risk factor for cardiovascular diseases].
Cibičková Ľ; Karásek D
Vnitr Lek; 2016; 62(11):919-923. PubMed ID: 28128580
[TBL] [Abstract][Full Text] [Related]
17. Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis.
Aibibula Z; Ailixiding M; Iwata M; Piao J; Hara Y; Okawa A; Asou Y
Biochem Biophys Res Commun; 2016 Mar; 472(1):26-32. PubMed ID: 26903297
[TBL] [Abstract][Full Text] [Related]
18. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
Schils R; Krzesinski JM
Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
[TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia, gout and the metabolic syndrome.
Puig JG; Martínez MA
Curr Opin Rheumatol; 2008 Mar; 20(2):187-91. PubMed ID: 18349749
[TBL] [Abstract][Full Text] [Related]
20. Uric acid and cardiovascular risk.
Parmar MS
N Engl J Med; 2009 Jan; 360(5):539; author reply 540-1. PubMed ID: 19186310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
